Viewing nowCrebatin Tablet 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201501811 · Approved 2015.04.02 · Insurance code 649404760
Improvement of dyslipidemia; inhibition of atherosclerosis progression; prevention of cardiovascular disease
This medication is used as an adjunct when diet and exercise do not adequately control primary hypercholesterolemia and mixed dyslipidemia. It is also prescribed as an adjunct to diet or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. This drug effectively lowers total cholesterol and LDL-cholesterol levels, thereby delaying the progression of atherosclerosis. It is particularly used in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia to reduce LDL-cholesterol and Apo-B protein levels. It is also applied as an adjunct to diet in patients with primary dysbetalipoproteinemia and is helpful in reducing the risk of cardiovascular diseases such as myocardial infarction and stroke in high-risk groups with elevated high-sensitivity C-reactive protein levels. Overall, this drug is used to improve blood lipid levels and reduce the risk of cardiovascular diseases.
Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. Older adults: No dosage adjustment is necessary. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. First, patients who are allergic to this medication or have severe liver dysfunction, those with muscle disorders, patients with severely impaired renal function, and women who are pregnant or breastfeeding should not take this drug. Additionally, patients at high risk for muscle issues should avoid high doses of this medication, and those with genetic problems such as lactose intolerance should not take it either. When using this medication, liver function and muscle condition should be regularly monitored, and especially if symptoms like muscle pain, muscle weakness, or muscle cramps occur, medical personnel should be notified immediately. Patients who consume alcohol heavily or have a history of liver disease, as well as those with hypothyroidism, should use this drug with caution and may need to repeat liver enzyme tests. This drug can interact with other medications, so if other medications are being taken, it is important to inform the physician or pharmacist. In particular, when taken with certain antiviral medications, immunosuppressants, or fibrate-based drugs, the risk of muscle disorders may increase. Women who may become pregnant should ensure proper contraception while taking this drug, and it should not be used during pregnancy. Breastfeeding women should also avoid this medication. There is no specific antidote in case of overdose, and treatment should be based on symptoms while monitoring liver function and muscle enzyme levels. This drug does not significantly affect the ability to drive or operate machinery, but caution is needed due to possible dizziness. Finally, if severe skin reactions like rash, swelling, or difficulty breathing occur while taking this medication, use should be stopped immediately and medical consultation should be sought.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Pink round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.